Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Kanarek

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Ondansetron is not associated with vascular adverse events, thrombocytopenia or renal failureW M Castle, K Cunningham, B B Kanarek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Ondansetron: confusing documentation surrounding an extrapyramidal reactionB B Kanarek, R Curnow, J Palmer, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Ondansetron is not associated with vascular adverse events, thrombocytopenia or renal failureW M Castle, K Cunningham, B B Kanarek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Ondansetron: confusing documentation surrounding an extrapyramidal reactionB B Kanarek, R Curnow, J Palmer, et al.
Pageof 1